SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-012444 to ATLANTIC INTERNATIONAL CORP. (ATLN)

ATLANTIC INTERNATIONAL CORP.
Date: Nov. 13, 2023 · CIK: 0001605888 · Accession: 0000000000-23-012444

Financial Reporting Regulatory Compliance Risk Disclosure

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-272908

Date
November 13, 2023
Author
Daniel Jones
Form
UPLOAD
Company
ATLANTIC INTERNATIONAL CORP.

Letter

United States securities and exchange commission logo November 13, 2023 Daniel Jones Chief Executive Officer SeqLL, Inc. 3 Federal Street Billerica, MA 01821 Re:SeqLL, Inc. Amendment No. 8 to Registration Statement on Form S-1 Filed November 13, 2023 File No. 333-272908 Dear Daniel Jones: We have reviewed your amended registration statement and have the following comments. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our November 9, 2023 letter. Amendment No. 8 to Registration Statement on Form S-1, Filed November 13, 2023 Cover Page 1.We note your disclosure on the prospectus cover page that your "common stock is currently listed for trading on the Nasdaq Capital Market under the symbol 'SQL.'" We also note your disclosure on page 5 that Nasdaq has determined to delist your securities from Nasdaq and suspend trading in those securities effective at the open of trading on November 13, 2023, that you have requested a hearing and that discussions with Nasdaq are continuing. Please revise the cover page to update and confirm your listing status. If the securities being offered are not listed on a national securities exchange, please disclose the principal United States market where the company has sought and achieved quotation. Refer to Item 501(b)(4) of Regulation S-K.

FirstName LastNameDaniel Jones Comapany NameSeqLL, Inc. November 13, 2023 Page 2 FirstName LastName Daniel Jones SeqLL, Inc. November 13, 2023 Page 2 Prospectus Summary, page 1 2.We note your disclosure on page 23, as well as the disclosure on page 49, describing the substantial doubt in Lyneer's ability to continue as a going concern. Please include such disclosure in this section, including whether you expect that Lyneer's existing cash balances will be sufficient to meet working capital and capital expenditure needs for the next twelve months. Please include cross-references to the applicable risk factors and your Liquidity & Capital Resources discussion. Additionally, please update the Modifications to Lyneer's Debt Facilities section on page 5 to disclose the most up to date information regarding Lyneer's debt facilities. In this regard, we note your disclosure throughout the prospectus that Lyneer does not expect to cure such events of default prior to November 17, 2023 and has not obtained an extension of the Forbearance Agreement. Please contact Ta Tanisha Meadows at 202-551-3322 or Theresa Brillant at 202-551- 3307 if you have questions regarding comments on the financial statements and related matters. Please contact Nicholas Nalbantian at 202-551-7470 or Donald Field at 202-551-3680 with any other questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Eric M. Hellige

Show Raw Text
United States securities and exchange commission logo
November 13, 2023
Daniel Jones
Chief Executive Officer
SeqLL, Inc.
3 Federal Street
Billerica, MA 01821
Re:SeqLL, Inc.
Amendment No. 8 to Registration Statement on Form S-1
Filed November 13, 2023
File No. 333-272908
Dear Daniel Jones:
            We have reviewed your amended registration statement and have the following
comments.
            Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
            After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments. Unless we note otherwise,
any references to prior comments are to comments in our November 9, 2023 letter.
Amendment No. 8 to Registration Statement on Form S-1, Filed November 13, 2023
Cover Page
1.We note your disclosure on the prospectus cover page that your "common stock is
currently listed for trading on the Nasdaq Capital Market under the symbol 'SQL.'"  We
also note your disclosure on page 5 that Nasdaq has determined to delist your securities
from Nasdaq and suspend trading in those securities effective at the open of trading on
November 13, 2023, that you have requested a hearing and that discussions with Nasdaq
are continuing. Please revise the cover page to update and confirm your listing status. If
the securities being offered are not listed on a national securities exchange, please disclose
the principal United States market where the company has sought and achieved
quotation. Refer to Item 501(b)(4) of Regulation S-K.

 FirstName LastNameDaniel Jones
 Comapany NameSeqLL, Inc.
 November 13, 2023 Page 2
 FirstName LastName
Daniel Jones
SeqLL, Inc.
November 13, 2023
Page 2
Prospectus Summary, page 1
2.We note your disclosure on page 23, as well as the disclosure on page 49, describing the
substantial doubt in Lyneer's ability to continue as a going concern. Please include such
disclosure in this section, including whether you expect that Lyneer's existing cash
balances will be sufficient to meet working capital and capital expenditure needs for the
next twelve months. Please include cross-references to the applicable risk factors and your
Liquidity & Capital Resources discussion. Additionally, please update the Modifications
to Lyneer's Debt Facilities section on page 5 to disclose the most up to date information
regarding Lyneer's debt facilities. In this regard, we note your disclosure throughout the
prospectus that Lyneer does not expect to cure such events of default prior to November
17, 2023 and has not obtained an extension of the Forbearance Agreement.
            Please contact Ta Tanisha Meadows at 202-551-3322 or Theresa Brillant at 202-551-
3307 if you have questions regarding comments on the financial statements and related
matters. Please contact Nicholas Nalbantian at 202-551-7470 or Donald Field at 202-551-3680
with any other questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:       Eric M. Hellige